Top Banner
Arvind INGLE MVSc. (Path.), Ph.D., Diplomate ICVP, FNAVS Scientific Officer ‘G’ & Officer-in-Charge, Laboratory Animal Facility & Histopathology. ACTREC, Tata Memorial Centre, Mumbai, India. http://actrec.gov.in/animal_main.htm
27

Arvind INGLE - asas.or.jp

Feb 24, 2022

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Arvind INGLE - asas.or.jp

Arvind INGLE

MVSc. (Path.), Ph.D., Diplomate ICVP, FNAVS

Scientific Officer ‘G’ &

Officer-in-Charge,

Laboratory Animal Facility & Histopathology.

ACTREC, Tata Memorial Centre, Mumbai, India.

http://actrec.gov.in/animal_main.htm

Page 2: Arvind INGLE - asas.or.jp

Background

The 3Rs concept was first described by William Russell and Rex Burch in 1959.

Replace animal tests by alternative methods,

wherever possible.

Reduce the number of animals, wherever possible, while still achieving testing objectives.

Refine methods to lessen or eliminate pain or distress in animals, or enhances animal well-being.

Page 3: Arvind INGLE - asas.or.jp

Animal research- use of animals in research.

Animal testing- drugs safety testing.

Animal Research and Testing

Page 4: Arvind INGLE - asas.or.jp

Background

o U.S. regulatory agencies- testing of consumer products, medicines, and industrial and agricultural chemicals to identify potential health and safety hazards.

o Appropriate hazard classification and labelling, which in turn enables informed decisions about responsible use, storage, and disposal.

o Must be based on ‘sound science’ and able to adequately identify hazards.

Page 5: Arvind INGLE - asas.or.jp

Background

Responses to chemicals are complex and difficult to

accurately assess using only biochemical or cell-based (“in

vitro”) systems or computer models.

No single in vitro test method- to serve all regulatory needs

for a specific testing area.

Severe eye irritants and substances that could cause allergic

contact dermatitis- major progress has been made in

reducing and replacing animal use.

For other hazards that can cause cancer or birth defects,

development of in vitro tests that reliably identify hazards is

more difficult because of the number of different

mechanisms involved in these complex biological

processes.

Page 6: Arvind INGLE - asas.or.jp

Ground reality

Animal research does occur and we

need to know our responsibilities?

The IACUC is legally required to

oversee all animal care and use

activities conducted at the

institution.

Set high ethical and welfare

standards.

Page 7: Arvind INGLE - asas.or.jp

C P C S E A

Integrate the Three R’s in all R&D

processes and Procedures.

Review animal models on a continuous

basis for replacement with alternatives.

Use human cells and tissues instead of

living animals, wherever possible.

Page 8: Arvind INGLE - asas.or.jp

How does the committee exercise

their responsibilities?

They review and approve all research, testing

activities that involve animals before scientists begin

their experiments to ensure:

there are no alternatives to using animals,

that research is not being unnecessarily duplicated, and

that the experiment is relevant to human or animal health

and will be for the good of the society.

Page 9: Arvind INGLE - asas.or.jp

Alternatives

Zebra fish

Zebra fish share many genes with humans.

Physiology, and developmental similarity.

Tg fish for cancer development.

Page 10: Arvind INGLE - asas.or.jp

Zebra fish as a model for cancer and metastasis

Lymphoblastic leukemia Feitsma and Cuppen, 2008

Page 11: Arvind INGLE - asas.or.jp

Angiogenesis

Tobia et al, 2011

Page 12: Arvind INGLE - asas.or.jp

Zebra fish as a model for metastasis

MDA231 Teng et al, 2013

Page 13: Arvind INGLE - asas.or.jp

Alternatives

Artificial tumor/ hydrogel/ Stem cells.

The microenvironment has a significant effect on how

the cells respond to a drug.

Page 14: Arvind INGLE - asas.or.jp

Refinements

Reduce the number of animals, wherever

possible, while still achieving testing

objectives.

Refine methods.

Page 15: Arvind INGLE - asas.or.jp

Refinements

Mouse models in cancer research.

Relevant animal model- early stage to

metastasis.

Page 16: Arvind INGLE - asas.or.jp

Refinements cont…..

Nude mice

-T-cell (+B- and NK cell).

characterization of cancer cell lines.

NIH-III: T-, B- & NK.

SCID mice, 1983: T- & B-cells

Tg/ KO (GEMM)

Hairless SCID: T- & B-cells

Normal innate immune system.

Page 17: Arvind INGLE - asas.or.jp

Super specialized models

SCID beige- T-, B- & NK cells

NOD SCID- T-, B- & NK cells

Rag-1 & Rag-2 KO

NSG/ NOG- support metastasis.

Page 18: Arvind INGLE - asas.or.jp

Other refinements

Leakiness

Recurrent infections

Site of injection/ transplant

s/c or orthotopic (same microenvironment)

Show faster early-stage tumor growth,

angiogenesis and hyper-permeability of blood

vessels compared to ectopic tumors.

Harmone dependency- breast and prostate

Implantation of microenvironment /matrigel.

Page 19: Arvind INGLE - asas.or.jp

Refinements

Spontaneously developing tumor models-

MMTV, leukemia, breast cancer, lung

cancer, brain cancer etc.

Page 20: Arvind INGLE - asas.or.jp

Refined models

T-, B-cell profile

In vivo testing

Molecular testing of tumor growth_PCR

Page 21: Arvind INGLE - asas.or.jp

T- cell assessment

Page 22: Arvind INGLE - asas.or.jp

T- and B- cell assessment

Page 23: Arvind INGLE - asas.or.jp

Confirmation of tumor grown

Forward primers 5’ -TGCCATTTGTGGGTACATTC- 3’

Reverse primer 5’ -TTGTGTTTCTTTTTCTGTTCCTACA- 3’

Page 24: Arvind INGLE - asas.or.jp

Short Tandem Repeats

275

bp

1 2 3 4 5 6 7 8 9 10 11 12 13

DNA of the human oral cavity tumor, thigh muscle tumor, breast

tumor, brain tumor, neuroblastoma, and meningioma.

Page 25: Arvind INGLE - asas.or.jp

Single Nucleotide Polymorphism

DNA of primary tumor

DNA of the established tumor.

Page 26: Arvind INGLE - asas.or.jp

Summarize with two final points

1. Using animals for research activities is a

privilege, not a right!

2. It is a privilege that a scientist or an

institution can loose if the ethical (e.g.

legal and moral) responsibilities are not

satisfied.

Page 27: Arvind INGLE - asas.or.jp

ACTREC

Thank you